Abstract
To find new potentially therapeutic drugs against clear cell Renal Cell Carcinoma (ccRCC), within drugs currently prescribed for other diseases (drug repositioning), we previously searched for drugs which are expected to bring the gene expression of 500 + ccRCC samples from The Cancer Genome Atlas closer to that of healthy kidney tissue samples. An inherent limitation of this bulk RNA-seq data is that tumour samples consist of a varying mixture of cancerous and non-cancerous cells, which influences differential gene expression analyses. Here, we investigate whether the drug repositioning candidates are expected to target the genes dysregulated in ccRCC cells by studying the association with tumour purity. When all ccRCC samples are analysed together, the drug repositioning potential of identified drugs start decreasing above 80% estimated tumour purity. Because ccRCC is a highly vascular tumour, attributed to frequent loss of VHL function and subsequent activation of Hypoxia-Inducible Factor (HIF), we stratified the samples by observed activation of the HIF-pathway. After stratification, the association between estimated tumour purity and drug repositioning potential disappears for HIF-activated samples. This result suggests th...Continue Reading
References
Sep 30, 2006·Science·Justin LambTodd R Golub
Mar 3, 2007·Journal of Medicinal Chemistry·Kyeong LeeJung Joon Lee
Apr 30, 2009·Cancer·Chao-Nan QianBin Tean Teh
Jan 16, 2013·Journal of Translational Medicine·Saadia A AzizHarriet M Kluger
Jun 25, 2013·Nature·UNKNOWN Cancer Genome Atlas Research Network
Oct 22, 2013·Nature Methods·Angela R WuStephen R Quake
Dec 18, 2013·Cancer Cell·Lianjie LiWilliam G Kaelin
Aug 27, 2014·Cancer Cell·Caleb F DavisChad J Creighton
Sep 3, 2014·PloS One·Mehmet Kemal Samur
Nov 5, 2015·The New England Journal of Medicine·W Marston LinehanUNKNOWN Cancer Genome Atlas Research Network
Dec 5, 2015·Nature Communications·Dvir AranAtul J Butte
Dec 15, 2015·Bioinformatics·Petr SmirnovBenjamin Haibe-Kains
Dec 26, 2015·Nucleic Acids Research·Antonio ColapricoHoutan Noushmehr
Mar 8, 2016·Cell Reports·Fengju ChenChad J Creighton
Jul 21, 2016·Scientific Reports·Stefan WinterElke Schaeffeler
Mar 10, 2017·Nature Reviews. Disease Primers·James J HsiehVincenzo Ficarra
Apr 12, 2017·Nature Biotechnology·John VivianBenedict Paten
May 30, 2017·Nature Medicine·Sabine HarlanderIan J Frew
Jun 29, 2017·International Journal of Cancer. Journal International Du Cancer·Xingwen WangYing Hu
Dec 5, 2017·Cell Systems·Alexandra B KeenanAjay Pillai
Mar 24, 2018·F1000Research·Shahzaib NabiElaine T Lam
Mar 29, 2018·Scientific Reports·Karel K M KoudijsHenk-Jan Guchelaar